These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1969348)

  • 41. Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients.
    Del Prato S; Riccio A; Vigili de Kreutzenberg S; Dorella M; Avogaro A; Marescotti MC; Tiengo A
    Metabolism; 1993 Jan; 42(1):24-9. PubMed ID: 8446044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis of insulinoma using the ratios of serum concentrations of insulin and C-peptide to glucose during a 5-hour oral glucose tolerance test.
    Li X; Zhang F; Chen H; Yu H; Zhou J; Li M; Li Q; Li L; Yin J; Liu F; Bao Y; Han J; Jia W
    Endocr J; 2017 Jan; 64(1):49-57. PubMed ID: 27725372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Insulinoma: diagnostic elements. 13 cases].
    Hazard J; Simon D; Perlemuter L; Requeda E; Jamin C; Julien M; Fagniez PL; Belaiche J; Bernheim R
    Presse Med; 1985 Oct; 14(34):1775-8. PubMed ID: 2999755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Control of basal insulin secretion, with special reference to the diagnosis of insulinomas.
    Turner RC; Oakley NW; Nabarro JD
    Br Med J; 1971 Apr; 2(5754):132-5. PubMed ID: 4325738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nightly amended IRI/BG ratio in fasting test during sleeping periods in subjects with insulinoma and in normal, diabetic and obese subjects.
    Villaume C; Beck B; Dollet JM; Pointel JP; Drouin P; Debry G
    Acta Diabetol Lat; 1984; 21(4):325-32. PubMed ID: 6099025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical presentation in insulinoma predicts histopathological tumour characteristics.
    Wolf P; Winhofer Y; Smajis S; Anderwald CH; Scheuba C; Niederle B; Gessl A; Luger A; Krebs M; Koperek O
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):67-71. PubMed ID: 25817061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The C-peptide suppression test in normal persons and insulinoma patients: an attempt to evaluate its use in functional diagnosis (author's transl)].
    Mandelkow H; Goetz K; Kühnau J
    Klin Wochenschr; 1981 Nov; 59(21):1209-15. PubMed ID: 6273644
    [No Abstract]   [Full Text] [Related]  

  • 49. Short fasting test as a reliable and effective tool to diagnose insulinoma.
    Mikovic N; Mazzilli R; Zamponi V; Russo F; Mancini C; Mori F; Bollanti L; Conti F; Motta C; Monti S; Pugliese G; Faggiano A
    Endocrine; 2024 Jun; 84(3):1258-1263. PubMed ID: 38451386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beta cell response to the hyperglycaemic clamp in three patients with insulinoma: a study using a hyperglycaemic glucose clamp.
    García López JM; De la Fuente A; Tomé MA; Cabezas-Cerrato J
    Horm Metab Res; 1987 Apr; 19(4):160-3. PubMed ID: 3034753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intra-arterial calcium stimulation test for detection of insulinomas: detection rate, responses of pancreatic peptides, and its relationship to differentiation of tumor cells.
    Won JG; Tseng HS; Yang AH; Tang KT; Jap TS; Kwok CF; Lee CH; Lin HD
    Metabolism; 2003 Oct; 52(10):1320-9. PubMed ID: 14564685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Levy JC; Rudenski A; Burnett M; Knight R; Matthews DR; Turner RC
    Diabetologia; 1991 Jul; 34(7):488-99. PubMed ID: 1916054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Editorial: Diagnosis of insulinoma.
    Lancet; 1974 Aug; 2(7877):385-6. PubMed ID: 4136659
    [No Abstract]   [Full Text] [Related]  

  • 54. Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma.
    Battezzati A; Terruzzi I; Perseghin G; Bianchi E; Di Carlo V; Pozza G; Luzi L
    Diabetes; 1995 Jul; 44(7):837-44. PubMed ID: 7789652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of endocrine tests. D: the prolonged fasting test for insulinoma.
    van Bon AC; Benhadi N; Endert E; Fliers E; Wiersinga WM
    Neth J Med; 2009; 67(7):274-8. PubMed ID: 19687521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of a computerized glucose clamp technique to diagnose an insulinoma.
    Reynolds JH; Kaminsky NI; Schade DS; Eaton RP
    Ann Intern Med; 1984 Nov; 101(5):648-9. PubMed ID: 6091512
    [No Abstract]   [Full Text] [Related]  

  • 57. [Case of pancreatic insulinoma in a 15-year-old girl].
    Pach K; Stepniewska E
    Wiad Lek; 1983 Feb; 36(3):235-40. PubMed ID: 6305037
    [No Abstract]   [Full Text] [Related]  

  • 58. The diagnosis of insulinoma in a child in the absence of fasting hyperinsulinemia.
    Wolfsdorf JI; Senior B
    Pediatrics; 1979 Oct; 64(4):496-8. PubMed ID: 226922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intraoperative biochemical localization of insulinomas by quick radioimmunoassay.
    Teichmann RK; Spelsberg F; Heberer G
    Am J Surg; 1982 Jan; 143(1):113-5. PubMed ID: 6274209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulinoma associated with a case of multiple endocrine neoplasia type I: Functional somatostatin receptors and abnormal glucose-induced insulin secretion.
    Waeber G; Gomez F; Bishof-Delaloye A; Chaubert P; Francke ML; Haefliger JA; Scherrer U; Centeno G; Temler E; Nicod P
    Horm Res; 1997; 48(2):76-82. PubMed ID: 9251924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.